Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : URMD -- Huge market potential -- Ignore unavailable to you. Want to Upgrade?

To: Samuel J. Bennett who wrote (164)	12/2/1997 10:30:00 AM
From: Ken M	Read Replies (1) \| Respond to of 369

PR Newswire, Tuesday, December 02, 1997 at 09:25 MultiPlan, Covering Approximately 20 Million Lives, is Expanding Their Network To Include UroMed as a Continence Care Provider NEEDHAM, Mass., Dec. 2 /PRNewswire/ -- UroMed Corporation (NASDAQ:URMD), a company committed to men's and women's health care, today announced that UroMed will be a Preferred Provider of continence care products within the MultiPlan, Inc. Network. MultiPlan covers approximately 20 million lives. UroMed's continuum of covered continence care products includes the Reliance(R) Urinary Control Insert, the INTROL(R) Bladder Neck Support Prosthesis and the Impress(TM) Softpatch -- all FDA-cleared for marketing, as well as the PelvicFlex(TM) Personal Trainer Video. All of these products offer relief to the millions of American women who suffer from stress urinary incontinence. John G. Simon, UroMed's chairman of the board and chief executive officer commented, "Women deserve access to the superior solutions for incontinence that we alone offer. We are pleased that MultiPlan has agreed to include UroMed as part of their network available to their varied client base of insurance carriers and self-insured organizations, including numerous employer and labor management plans, as well as governmental agencies." MultiPlan, Inc., based in New York City, is one of the largest and oldest PPOs in the United States, serving more than 20 million lives nationwide. MultiPlan's approach, indicated by its corporate motto "America's managed care partner," allows it to offer access to healthcare in 49 states. MultiPlan is a Preferred Provider Organization which offers its members more than 50,000 providers and 23,000 facilities including more than 40 percent of the acute care hospitals in the nation. UroMed's preferred provider status would provide MultiPlan enrollees access to UroMed's products. UroMed, founded in October 1990, is dedicated to establishing itself as a leader in the development of male and female healthcare products. UroMed has three primary areas of initial focus: breast cancer, prostate cancer and incontinence. In the area of incontinence UroMed offers the Reliance Urinary Control Insert and the INTROL Bladder Neck Support Prosthesis -- both FDA-cleared for marketing, as well as the PelvicFlex Personal Trainer Video. In addition, next year UroMed will be offering its FDA-cleared continuum of care products, the Impress Softpatch, and the BEACON Technology System(TM), a minimally invasive incontinence surgical line. In the area of breast cancer, UroMed is developing its BreastCheck(TM) breast self examination device together with its physician-use BreastExam(TM) counterpart device. Both devices may potentially enhance breast cancer detection. The BreastCheck technology is an investigational technology and may be available to women in the U.S. as early as the first part of 1999 if FDA approval is obtained within that time frame. In the area of prostate cancer UroMed is pleased to offer the CaverMap(TM) Surgical Aid system. UroMed also continues to dedicate significant resources to the development and/or acquisition of new options that fit into UroMed's continuum of care in male and female healthcare. INTROL Bladder Neck Support Prosthesis and Reliance Urinary Control Insert are registered trademarks of UroMed Corporation. Impress Softpatch, PelvicFlex Personal Trainer Video, BEACON Technology System, BreastCheck, BreastExam and CaverMap Surgical Aid are trademarks of UroMed Corporation. SOURCE UroMed Corporation -0- 12/02/97 /CONTACT: Kristen Galfetti, Manager of Investor Relations of UroMed Corporation, 617-433-0033; or Elizabeth McWilliams, Account Executive of Ruder-Finn, 212-715-1565, for UroMed/